Strain Profile
Save

Lacticaseibacillus rhamnosus Lcr35

◐ Food-origin
Sequenced
Public genome assembly available

Lacticaseibacillus rhamnosus Lcr35 (formerly Lactobacillus casei rhamnosus Lcr35) has been evaluated in several randomized controlled trials across distinct clinical contexts, including pediatric chronic constipation, vaginal microbiome restoration following antibiotic treatment for bacterial vaginosis, and irritable bowel syndrome. In vitro and in vivo (C. elegans model) work has also examined antimicrobial properties against Candida albicans, with sulfur-containing compounds studied as possible contributors. Animal model research has examined the strain in the context of asthma and intestinal mucositis; these have not been confirmed in human trials. These are research topics, not findings; the papers do not establish that this strain treats or prevents any condition.

Where it's been studied

Share of this strain's 62 body-system-tagged papers that concern each system. Research coverage, not measured effect.

+3 more systems

Symptoms in the research

Share of this strain's 39 symptom-tagged papers that mention each symptom or condition. Research coverage, not evidence of benefit.

+10 more symptoms

Research

71 papers reference this strain in the probiotic database.

Match confidence
2025 RCT
Enhanced sleep quality and reduced indoxyl sulfate levels following probiotic supplementation were linked to gut microbiota modulation in hemodialysis patients
· Journal of the Formosan Medical Association
2024 META_ANALYSIS
Efficacy and acceptability of different probiotic products plus laxatives for pediatric functional constipation: a network meta-analysis of randomized controlled trials
· European Journal of Pediatrics
2022 IN_VITRO
In vivo investigation of Lcr35® anti-candidiasis properties in Caenorhabditis elegans reveals the involvement of highly conserved immune pathways
· Frontiers in Microbiology
2022 IN_VITRO
Lacticaseibacillus rhamnosus Lcr35 Stimulates Epithelial Vaginal Defenses upon Gardnerella vaginalis Infection
· Infection and Immunity
2021 ANIMAL
Immune Modulation Effects of Lactobacillus casei Variety rhamnosus on Enterocytes and Intestinal Stem Cells in a 5-FU-Induced Mucositis Mouse Model
· Gastroenterology Research and Practice
2020 ANIMAL
Immune modulation effects and safety of Lactobacillus casei variety rhamnosus in a chemotherapy-induced intestinal mucositis mouse model
· Research Square (Research Square)
2020 IN_VITRO
Identification of sulfur components enhancing the anti-Candida effect of Lactobacillus rhamnosus Lcr35
· Scientific Reports
2020 IN_VITRO
Caractérisation in vivo des propriétés antimicrobiennes de la souche probiotique Lcr35®
·
2020 ANIMAL
Combined Effects of Lactobacillus rhamnosus and Egg Oral Immunotherapy in a Mouse Model of Egg Allergy
· Allergy Asthma and Immunology Research
2020 IN_VITRO
Caractérisation in vivo des propriétés antimicrobiennes de la souche probiotique Lcr35
· theses.fr (ABES)
2020 IN_VITRO
In vivo characterization of the antimicrobial properties of the probiotic strain Lcr35®
· theses.fr (ABES)
2020 IN_VITRO
Caractérisation in vivo des propriétés antimicrobiennes de la souche probiotique Lcr35 ® Utilisation du modèle Caenorhabditis elegans pour l'étude des interactions hôte -microorganismes
· HAL (Le Centre pour la Communication Scientifique Directe)
2019 IN_VITRO
Lactobacillus rhamnosus Lcr35 as an effective treatment for preventing Candida albicans infection in the invertebrate model Caenorhabditis elegans: First mechanistic insights
· PLoS ONE
2019 IN_VITRO
Lactobacillus rhamnosus Lcr35 as an effective treatment for preventing Candida albicans infection in the preclinical model Caenorhabditis elegans
· HAL (Le Centre pour la Communication Scientifique Directe)
2019 OBSERVATIONAL
Therapy of bacterial vaginosis
· Meditsinskiy sovet = Medical Council
2019 IN_VITRO
Lactobacillus rhamnosus Lcr35 en tant que traitement efficace contre l'infection à Candida albicans dans le modèle préclinique Caenorhabditis elegans
· HAL (Le Centre pour la Communication Scientifique Directe)
2019 IN_VITRO
Lactobacillus rhamnosus Lcr35 ® as an effective treatment for preventing Candida albicans infection in preclinical models: first mechanistical insights
· bioRxiv (Cold Spring Harbor Laboratory)
2019 IN_VITRO
Curative Treatment of Candidiasis by the Live Biotherapeutic Microorganism Lactobacillus rhamnosus Lcr35® in the Invertebrate Model Caenorhabditis elegans: First Mechanistic Insights
· Microorganisms
2019 RCT
Traitement de l'aphtose buccale récidivante et idiopathique de l'adulte par probiotiques : étude interventionnelle randomisée en double aveugle versus placebo
· INRIA a CCSD electronic archive server
2018 RCT
Comparative phase I randomized open-label pilot clinical trial of Gynophilus® (Lcr regenerans®) immediate release capsules versus slow release muco-adhesive tablets
· European Journal of Clinical Microbiology & Infectious Diseases
Browse all 71 papers →

Discussion

Be the first to comment.

Sign in to join the discussion.

No comments yet.

Citations

Selected papers that name this strain.

  1. [1]
    Immune modulation effects and safety of Lactobacillus casei variety rhamnosus in a chemotherapy-induced intestinal mucositis mouse model
    · Research Square (Research Square) · 2020
    Source →
  2. [2]
    Efficacy of a Triple Anti-Infective Regimen for Prevention of Complications in Critically Ill Term Neonates
    · Iranian Journal of Pediatrics · 2018
    Source →
  3. [3]
    Efficacy and safety profile of LCR35 complete freeze-dried culture in irritable bowel syndrome: A randomized, double-blind study
    · World Journal of Gastroenterology · 2012
    PMID 22563194 →
  4. [4]
    Routine Probiotic Use in Very Preterm Infants: Retrospective Comparison of Two Cohorts
    · American Journal of Perinatology · 2012
    PMID 22773285 →
  5. [5]
    The role of Lactobacillus casei rhamnosus Lcr35 in restoring the normal vaginal flora after antibiotic treatment of bacterial vaginosis
    · BJOG An International Journal of Obstetrics & Gynaecology · 2008
    PMID 18823487 →
  6. [6]
    Lactobacillus casei rhamnosus Lcr35 in children with chronic constipation
    · Pediatrics International · 2007
    PMID 17587273 →
  7. [7]
    Persistence of Colonization of Intestinal Mucosa by a Probiotic Strain, Lactobacillus casei subsp. rhamnosus Lcr35, after Oral Consumption
    · Journal of Clinical Microbiology · 2003
    PMID 12624065 →